OBJECTIVE: Coronary artery bypass graft surgery remains associated with significant postoperative cardiovascular morbidity and mortality in high-risk patients.
What does CABG stand for?
CABG stands for Coronary Artery Bypass Graft (cardiology)
This definition appears very frequently and is found in the following Acronym Finder categories:
- Science, medicine, engineering, etc.
See other definitions of CABG
We have 54 other meanings of CABG in our Acronym Attic
- Concanavalin A-Binding Fraction (cholesterol)
- Coronary Artery Blood Flow
- Center for the Advancement of Banking & Financial Services (Indian Business School; Mumbai, India)
- Carotid Artery Blood Flow Velocity
- Carotid Artery Blood Flow Waveform
- Cardiac Artery Bypass Graft (less common)
- Clone Army Builders Guild (modeling club)
- Concanavalin A-Binding Glycoprotein (internal medicine)
- Coronary Angioplasty Bypass Grafting (cardiology)
- Coronary Aorta Bypass Grafting (cardiovascular medicine)
- Chip Array Ball Grid Array
- Cabinda Gulf Oil Company Ltd
- Coronary Artery Bypass Graft Surgery
- Central Animal Breeding House (University of Queensland; Australia)
- Consumers Association in Bosnia and Herzegovina (Sarajevo, Bosnia and Herzegovina)
- Conventional-direction Asymmetric Branch-line Hybrid (microwave integrated circuit)
- Committee on Agricultural Biotechnology, Health, and the Environment
- Center for Applied Behavioral Health Policy (Phoenix, AZ)
- Center for Addiction and Behavioral Health Research (University of Wisconsin-Milwaukee)
- Child and Adolescent Behavioral Health Services (Minnesota)
Samples in periodicals archive:
Thirty patients scheduled for elective coronary artery bypass graft surgery were randomly assigned to receive 150-180 mg per day of coenzyme Q10 (CoQ10) or no CoQ10 (control group) for 7 to 10 days preoperatively.
Appendix The following additional information is provided in accordance with the Code of Best Practice for Reporting by Life Science Companies: A Randomized, Double-blind, Placebo-controlled study of Glypromate(R) in Patients undergoing Coronary Artery Bypass Graft Surgery Protocol Abbreviated Name: Studying Neurons Using Glypromate (SNUG) Name of Investigational Agent: Glypromate(R) (glycyl-L-prolyl-L-glutamate) Study Centres: 4 centres in New Zealand, 1 in Australia Phase of Development: 2a Objectives: Primary: To investigate the pharmacokinetics of Glypromate(R) in post-CABG patients Secondary: To monitor the safety profile of Glypromate(R) treatment compared to placebo in CABG patients.